Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): Follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort

  1. Gianni, L.
  2. Eiermann, W.
  3. Semiglazov, V.
  4. Lluch, A.
  5. Tjulandin, S.
  6. Zambetti, M.
  7. Moliterni, A.
  8. Vazquez, F.
  9. Byakhov, M.J.
  10. Lichinitser, M.
  11. Climent, M.A.
  12. Ciruelos, E.
  13. Ojeda, B.
  14. Mansutti, M.
  15. Bozhok, A.
  16. Magazzù, D.
  17. Heinzmann, D.
  18. Steinseifer, J.
  19. Valagussa, P.
  20. Baselga, J.
Aldizkaria:
The Lancet Oncology

ISSN: 1474-5488 1470-2045

Argitalpen urtea: 2014

Alea: 15

Zenbakia: 6

Orrialdeak: 640-647

Mota: Artikulua

DOI: 10.1016/S1470-2045(14)70080-4 GOOGLE SCHOLAR